MyOme is a pioneering company dedicated to providing clinically actionable genetic information to patients throughout their lives. By integrating clinical-grade sequencing with advanced genome interpretation methods, MyOme empowers patients to take control of their health data and share it as they see fit. The company is driven by a team of experienced entrepreneurs and scientists, supported by a distinguished group of investors, and is committed to enhancing the role of genetic information in personal and family health decisions.